Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05078164 · ClinicalTrials.gov registry record · NA

Preventing Firearm Violence in Youth: A Hospital-based Prevention Strategy

A NA study of Violence in Adolescence, sponsored by Virginia Commonwealth University.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
1
Study location

NCT05078164 is a NA study of Violence in Adolescence that is actively recruiting participants, run by Virginia Commonwealth University. The registered enrollment target is 300 participants, below the 749-participant average among 9 other Violence in Adolescence trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05078164, a NA study of Violence in Adolescence, is actively recruiting participants, sponsored by Virginia Commonwealth University.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

The goal of the study is to understand if hospital-based violence interventions are effective for reducing youth violence among violently injured youth. This study will allow researchers to learn more about the intervention's effectiveness. The researchers also want to understand if the violence intervention impacts other behaviors, such as firearm use, drug use, aggression, risky behaviors, and rates of violent re-injury.

Conditions Studied

Interventions

  • BEHAVIORAL Bridging the Gap (BTG)

Study Locations (1)

Virginia

  • Virginia Commonwealth University - Richmond

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2022-05-04
Est. Completion 2026-12
Phase NA

Sponsor

Virginia Commonwealth University

558 total trials

What the Registry Record Tells You About NCT05078164

The ClinicalTrials.gov registry entry for NCT05078164 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 749-participant average among 9 other Violence in Adolescence trials with a reported enrollment target (60% lower). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Violence in Adolescence appearing as the primary indexed condition, and to 1 intervention - of which Bridging the Gap (BTG) is the first listed.

NCT05078164 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT05078164 about?

NCT05078164 is a clinical study titled "Preventing Firearm Violence in Youth: A Hospital-based Prevention Strategy". The goal of the study is to understand if hospital-based violence interventions are effective for reducing youth violence among violently injured youth. This study will allow researchers to learn more about the intervention's effectiveness. The researchers also want to understand if the violence int...

What is the current status of trial NCT05078164?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2022-05-04. Estimated completion is 2026-12.

What conditions does trial NCT05078164 study?

This clinical trial studies the following conditions: Violence in Adolescence.

What interventions are being tested in trial NCT05078164?

The interventions under investigation include: Bridging the Gap (BTG) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05078164?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05078164 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Violence in Adolescence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.